After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...

Nurx, a leading telehealth platform specializing in women's health, is excited to announce an integration agreement with ...

(Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) This could end up making your wallet lighter if you are ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lillyand Co. (LLY), American ...

UnitedHealth Group is well-positioned with improved guidance for 2025, but faces ongoing challenges. Read why I maintain my ...

Eli Lilly on Thursday expanded its direct-to-consumer online platform LillyDirect to include telehealth providers to diagnose ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling ...

After months of legal challenges, the FDA gave smaller pharmacies ... about $200 a month — about one-fifth the list price for Zepbound and less than half the price Lilly charges self-paying ...